Aura Biosciences AURA
NASDAQ AURA
$7.61 -0.04 (-0.52%)
At close: Nov 11, 2026 · 4:00 PM EST

Aura Biosciences (AURA) Other Operating Expenses (2022)

Updated

Aura Biosciences' Other Operating Expenses was $5,000 in Q2 2022.

Analysis

Aura Biosciences (AURA) Other Operating Expenses (2022) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Aura Biosciences 796.17 Mn 542.36 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 5,000.00
API Access

Aura Biosciences Other Operating Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-operating-expenses&ticker=AURA&period=max&api_key=YOUR_API_KEY